Kiora Pharmaceuticals Inc

NASDAQ:KPRX  
0.57
-0.01 (-1.98%)
6:17:36 PM EDT: $0.57 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Kiora Pharmaceuticals Inc Stock, NASDAQ:KPRX

332 Encinitas Boulevard, Suite 102, Encinitas, California 92024
United States of America
Phone: +1.858.224.9600
Number of Employees: 12

Description

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.